ConductScience.org, home

Paper23909008

Vaccines and vaccination against yellow fever. WHO position paper -- June 2013.

Wkly Epidemiol Rec, 2013. Cited by 118 papers, by iCite.

Cite this record

ConductScience Library. Vaccines and vaccination against yellow fever. WHO position paper -- June 2013. Papers, record 23909008. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23909008

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Vaccines and vaccination against yellow fever. WHO position paper -- June 2013.
PubMed
Journal
Wkly Epidemiol Rec
PubMed
Year
2013
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
118
iCite
Relative citation ratio, by iCite
3.72
iCite
Revised in PubMed
2022-03-10
PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Mass VaccinationMajor topic
Yellow FeverMajor topic
Yellow Fever VaccineMajor topic
Cost-Benefit Analysis
Endemic Diseases
Humans
Immunity
Yellow fever virus

Source PubMed

Download CSV of topics

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT05332197Booster Vaccine for Yellow FeverBackgroundClinicalTrials.gov
NCT05644145Immunogenicity of Yellow Fever Vaccine in a Pediatric Population Vaccinated at 12-23 Months of Age in ArgentinaBackgroundClinicalTrials.gov

Download CSV of trials

Cited by77

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 118 citations.

PMIDTitleJournalYearIn PapersSource
42856775
Immunological Correlate of Protection by PHV02 Live, Attenuated Recombinant VSV Vaccine Against Nipah Virus Disease Using an Improved Neutralizing Antibody Method, with Considerations for Future Research.
Res Sq2026https://conductscience.org/library/papers/42856775PubMed
42797577Adverse Events Following Yellow Fever Vaccination in Older Adults in Colombia, 2024-2025: A National Pharmacovigilance Analysis.Vaccines (Basel)2026https://conductscience.org/library/papers/42797577PubMed
42447166Immunoprevention and immunomodulation of yellow fever: A scoping review of global and Latin American evidence.PLoS One2026https://conductscience.org/library/papers/42447166PubMed
40872893Bridging Gaps in Vaccine Access and Equity: A Middle Eastern Perspective.Vaccines (Basel)2025https://conductscience.org/library/papers/40872893PubMed
40733652A Single Dose of Yellow Fever Vaccine Provides Long-Term Immunity in Japanese Travelers.Vaccines (Basel)2025https://conductscience.org/library/papers/40733652PubMed
40432061From Antibodies to Immunity: Assessing Correlates of Flavivirus Protection and Cross-Reactivity.Vaccines (Basel)2025https://conductscience.org/library/papers/40432061PubMed
40333313Global Status of Adult Immunization Post COVID-19 Pandemic.Vaccines (Basel)2025https://conductscience.org/library/papers/40333313PubMed
40333208Safety and Efficacy of Vaccination During Lactation: A Comprehensive Review of Vaccines for Maternal and Infant Health Utilizing a Large Language Model Citation Screening System.Vaccines (Basel)2025https://conductscience.org/library/papers/40333208PubMed
40132321Identification of potential vaccines for use with microarray patches in low- and middle-income countries: An assessment from the Vaccine Innovation Prioritisation Strategy Alliance.Vaccine2025https://conductscience.org/library/papers/40132321PubMed
39935766
Booster Vaccination against Yellow Fever in Gambian children-(BoVY) -a Phase 3 clinical trial to establish safety and immunogenicity of repeated YF vaccination in healthy Gambian children of different ages.
Wellcome Open Res2024https://conductscience.org/library/papers/39935766PubMed
39424573The effect of BCG revaccination on the response to unrelated vaccines in urban Ugandan adolescents (POPVAC C): an open-label, randomised controlled trial.Lancet Glob Health2024https://conductscience.org/library/papers/39424573PubMed
38735993Advancing molecular modeling and reverse vaccinology in broad-spectrum yellow fever virus vaccine development.Sci Rep2024https://conductscience.org/library/papers/38735993PubMed
38567951Cynomolgus macaques as a translational model of human immune responses to yellow fever 17D vaccination.J Virol2024https://conductscience.org/library/papers/38567951PubMed
38155740Serological investigation of vaccine-induced antibodies for measles, rubella, and yellow fever viruses in children vertically exposed to Zika virus or with down syndrome.Front Pediatr2023https://conductscience.org/library/papers/38155740PubMed
38098643
Are the first 1,000 days of life a neglected vital period to prevent the impact on maternal and infant morbimortality of infectious diseases in Latin America? Proceedings of a workshop of experts from the Latin American Pediatric Infectious Diseases Society, SLIPE.
Front Pediatr2023https://conductscience.org/library/papers/38098643PubMed
37900033Mitigating the effects of climate change on human health with vaccines and vaccinations.Front Public Health2023https://conductscience.org/library/papers/37900033PubMed
37770632Immunological factors linked to geographical variation in vaccine responses.Nat Rev Immunol2024https://conductscience.org/library/papers/37770632PubMed
37433816YF17D-vectored Ebola vaccine candidate protects mice against lethal surrogate Ebola and yellow fever virus challenge.NPJ Vaccines2023https://conductscience.org/library/papers/37433816PubMed
37127045Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial.Lancet Infect Dis2023https://conductscience.org/library/papers/37127045PubMed
37000007Enhanced safety surveillance of STAMARIL® yellow fever vaccine provided under the expanded access investigational new drug program in the USA.J Travel Med2023https://conductscience.org/library/papers/37000007PubMed

See all 77 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Authors
  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23909008

GET https://conductscience.org/api/papers/v1/23909008/cited_by?page=2